Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

NCT01245179 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: panobinostat

Sponsor

Abdullah Kutlar

Collaborators

[object Object]